Shares of CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) have been given a consensus rating of “Hold” by the six research firms that are presently covering the company, Marketbeat reports. Five equities research analysts have rated the stock with a hold rating and one has issued a strong buy rating on the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $117.00.
A number of analysts recently issued reports on CHEOY shares. Jefferies Financial Group lowered CochLear from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 22nd. Zacks Research upgraded CochLear from a “strong sell” rating to a “hold” rating in a report on Monday, June 22nd. Finally, Royal Bank Of Canada lowered CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 target price for the company. in a research report on Thursday, July 16th.
Check Out Our Latest Research Report on CHEOY
CochLear Stock Performance
About CochLear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
See Also
- Five stocks we like better than CochLear
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
